病例报告：患有耐多药肺结核的寻求庇护者中携带碳青霉烯酶的肠杆菌科细菌。
Case Report: Carbapenemase-Producing Enterobacteriaceae in an Asylum Seeker with Multidrug-Resistant Tuberculosis.
机构信息
University of Groningen, University Medical Center Groningen, Department of Internal Medicine, Groningen, The Netherlands.
Department of Medical Microbiology, Tzaneio General Hospital of Piraeus, Athens, Greece.
出版信息
Am J Trop Med Hyg. 2018 Feb;98(2):376-378. doi: 10.4269/ajtmh.17-0544. Epub 2017 Dec 21.
Abstract
A Syrian asylum seeker with multidrug-resistant tuberculosis (TB) developed a bronchopleural fistula after pneumonectomy. Although screening tests were negative on admission, carbapenemase-producing Enterobacteriaceae were cultured after a few months of TB treatment. Prevalence of multidrug-resistant organisms is reported to be increased in asylum seekers compared with the general Dutch population. Arduous conditions during transit and interrupted health care delivery in our patient led to multiple-resistant microorganisms that complicated treatment.
摘要
一名患有耐多药结核病（TB）的叙利亚寻求庇护者在肺切除术后发生支气管胸膜瘘。尽管入院时的筛查检测结果为阴性，但在接受 TB 治疗数月后培养出了产碳青霉烯酶肠杆菌科细菌。与一般荷兰人群相比，报告称寻求庇护者中多药耐药生物的患病率有所增加。在我们的患者中，转运期间的艰苦条件和医疗服务的中断导致了多种耐药微生物的产生，使治疗变得复杂。
相似文献
1
Case Report: Carbapenemase-Producing Enterobacteriaceae in an Asylum Seeker with Multidrug-Resistant Tuberculosis.病例报告：患有耐多药肺结核的寻求庇护者中携带碳青霉烯酶的肠杆菌科细菌。
Am J Trop Med Hyg. 2018 Feb;98(2):376-378. doi: 10.4269/ajtmh.17-0544. Epub 2017 Dec 21.
2
High Prevalence of Infectious Diseases and Drug-Resistant Microorganisms in Asylum Seekers Admitted to Hospital; No Carbapenemase Producing Enterobacteriaceae until September 2015.住院寻求庇护者中传染病和耐药微生物的高流行率；截至2015年9月未发现产碳青霉烯酶肠杆菌科细菌。
PLoS One. 2016 May 4;11(5):e0154791. doi: 10.1371/journal.pone.0154791. eCollection 2016.
3
Trimethoprim-sulfamethoxazole for the treatment of carbapenem-resistant Enterobacteriaceae (CRE) infections.甲氧苄啶-磺胺甲恶唑用于治疗耐碳青霉烯类肠杆菌科细菌（CRE）感染。
Infect Dis (Lond). 2019 Jun;51(6):456-458. doi: 10.1080/23744235.2019.1580384. Epub 2019 Mar 11.
4
Impact of extensively drug-resistant tuberculosis on treatment outcome of multidrug-resistant tuberculosis patients with standardized regimen: report from Iran.广泛耐药结核病对标准化方案治疗的耐多药结核病患者治疗结局的影响：来自伊朗的报告。
Microb Drug Resist. 2010 Mar;16(1):81-6. doi: 10.1089/mdr.2009.0073.
5
[Tuberculosis in asylum seekers in The Netherlands].[荷兰寻求庇护者中的结核病]
Ned Tijdschr Geneeskd. 1997 Mar 22;141(12):581-4.
6
[Resistance to second-line drugs in migrants with multidrug-resistant tuberculosis in the Berlin region].
Pneumologie. 2014 Jul;68(7):496-500. doi: 10.1055/s-0034-1377226. Epub 2014 Jul 9.
7
IMP-6 Carbapenemase-Producing Enterobacteriaceae Bacteremia Successfully Treated with Amikacin-Meropenem in Two Patients.两例产IMP-6 碳青霉烯酶肠杆菌科菌血症患者采用阿米卡星-美罗培南成功治疗。
Pharmacotherapy. 2017 Oct;37(10):e96-e102. doi: 10.1002/phar.1984. Epub 2017 Aug 23.
8
In vitro synergistic activity of clofazimine and other antituberculous drugs against multidrug-resistant Mycobacterium tuberculosis isolates.氯法齐明与其他抗结核药物对耐多药结核分枝杆菌分离株的体外协同活性。
Int J Antimicrob Agents. 2015 Jan;45(1):71-5. doi: 10.1016/j.ijantimicag.2014.09.012. Epub 2014 Oct 18.
9
The potential role of trimethoprim-sulfamethoxazole in the treatment of drug-resistant tuberculosis.甲氧苄啶-磺胺甲恶唑在耐多药结核病治疗中的潜在作用。
Future Microbiol. 2016;11(4):539-47. doi: 10.2217/fmb.16.2. Epub 2016 Apr 12.
10
Interactions of linezolid and second-line anti-tuberculosis agents against multidrug-resistant Mycobacterium tuberculosis in vitro and in vivo.利奈唑胺与二线抗结核药物对耐多药结核分枝杆菌的体内外相互作用
Int J Infect Dis. 2016 Nov;52:23-28. doi: 10.1016/j.ijid.2016.08.027. Epub 2016 Sep 7.
引用本文的文献
1
Commensal antimicrobial resistance mediates microbiome resilience to antibiotic disruption.共生抗菌耐药性介导微生物组对抗生素破坏的恢复能力。
Sci Transl Med. 2024 Jan 17;16(730):eadi9711. doi: 10.1126/scitranslmed.adi9711.
本文引用的文献
1
Extended spectrum β-lactamase producing Escherichia coli and Klebsiella pneumoniae: critical tools for antibiotic resistance pattern.产超广谱β-内酰胺酶的大肠杆菌和肺炎克雷伯菌：抗生素耐药模式的关键因素
J Basic Microbiol. 2017 Jun;57(6):460-470. doi: 10.1002/jobm.201700008. Epub 2017 Apr 11.
2
Shorter treatment for multidrug-resistant tuberculosis: the good, the bad and the ugly.耐多药结核病的短程治疗：利弊与隐忧
Eur Respir J. 2016 Dec;48(6):1800-1802. doi: 10.1183/13993003.01208-2016. Epub 2016 Oct 6.
3
Multidrug-resistant tuberculosis and migration to Europe.耐多药结核病与欧洲移民
Clin Microbiol Infect. 2017 Mar;23(3):141-146. doi: 10.1016/j.cmi.2016.09.009. Epub 2016 Sep 23.
4
Multidrug-resistant organisms in refugees: prevalences and impact on infection control in hospitals.难民中的多重耐药菌：患病率及其对医院感染控制的影响。
GMS Hyg Infect Control. 2016 Aug 9;11:Doc16. doi: 10.3205/dgkh000276. eCollection 2016.
5
Implementing tuberculosis entry screening for asylum seekers: the Groningen experience.为难民实施结核病入境筛查：格罗宁根的经验。
Eur Respir J. 2016 Jul;48(1):261-4. doi: 10.1183/13993003.00112-2016. Epub 2016 Mar 23.
6
Multidrug-resistant bacteria in unaccompanied refugee minors arriving in Frankfurt am Main, Germany, October to November 2015.2015 年 10 月至 11 月抵达德国美因河畔法兰克福的无人陪伴未成年难民中的耐多药细菌。
Euro Surveill. 2016;21(2). doi: 10.2807/1560-7917.ES.2016.21.2.30109.
7
Multidrug-resistant organisms detected in refugee patients admitted to a University Hospital, Germany June‒December 2015.2015 年 6 月至 12 月，德国某大学医院收治的难民患者中检出多种耐药菌。
Euro Surveill. 2016;21(2). doi: 10.2807/1560-7917.ES.2016.21.2.30110.
8
Multidrug-Resistant Tuberculosis Complicated by Nosocomial Infection with Multidrug-Resistant Enterobacteriaceae.耐多药结核病合并耐多药肠杆菌科细菌医院感染
Am J Trop Med Hyg. 2016 Mar;94(3):517-8. doi: 10.4269/ajtmh.15-0690. Epub 2016 Jan 11.
9
Highly successful treatment outcome of multidrug-resistant tuberculosis in the Netherlands, 2000-2009.2000 - 2009年荷兰耐多药结核病的高度成功治疗结果
Int J Tuberc Lung Dis. 2015 Apr;19(4):406-12. doi: 10.5588/ijtld.14.0838.
10
Carbapenemase-producing Enterobacteriaceae in Europe: a survey among national experts from 39 countries, February 2013.欧洲产碳青霉烯酶肠杆菌科细菌：39 个国家国家专家调查，2013 年 2 月。
Euro Surveill. 2013 Jul 11;18(28):20525. doi: 10.2807/1560-7917.es2013.18.28.20525.
Zotero 插件